Recently, it was also postulated that elevated levels of lactoferrin are associated with reduced expression of ERα and PR, and perhaps HER-2, and
therefore could contribute to the development of triple negative breast cancer (TNBC) phenotypes [15]. It was found that lactoferrin efficiently
downregulates ERα, PR, and HER-2, and the increased invasiveness and aggression of these breast cancer cell lines was attributed to the
lactoferrin-endothelin axis.
Based on the several experiments by Ha et al. [15], it was found that persistent exposure of breast cancer cells to lactoferrin resulted in
downregulation of the hormone receptors leading to the development of TNBC phenotypes. |